Article Text
Statistics from Altmetric.com
Description
We present a rare case of renal cell carcinoma (RCC) in a 58-year-old Hispanic woman presenting with progressive shortness of breath of 2 months duration. Physical examination was remarkable for jugular venous distension, pedal oedema and left flank fullness. An initial transthoracic echocardiogram revealed a large, greater than 4×3 cm solid mass extending from the inferior vena cava (IVC) into the right atrium (figure 1). Subsequently, a 64-slice contrast-enhanced axial helical CT scan of the chest, abdomen and pelvis revealed a very large lobulated heterogeneously enhancing mass 12.4×9.5 cm occupying most of the left kidney. There was evidence of contiguous tumour extension into the left renal vein and IVC. Tumour invasion into the posterior wall of the IVC, extending into the right atrium was demonstrated (figure 2). MR angiogram showed three left renal arteries supplying the tumour mass, which were treated with embolisation before surgery (figure 3).
On the basis of multimodality imaging, the tumour was staged at T3c. The cardiac tumour extension was initially resected with reconstruction of the posterior wall of the right atrium and IVC under cardiopulmonary bypass. Subsequently, left radical nephrectomy was performed. Pathology from both specimens confirmed clear-type RCC (figure 4).
Previous case reports have demonstrated metastatic RCC extending into the right atrium presenting as syncope.1 Our patient's heart failure symptoms were likely secondary to physical obstruction in the right atrium from the tumour extension. This rare presentation (1% cases) of RCC extending to the right atrium highlights the silent nature of RCC before being diagnosed. Although, the RCC along with its tumour extensions was successfully resected, the high risk of recurrence mandates lifelong surveillance.2
Learning points
Direct cardiac metastasis is an uncommon (1% cases) presentation of primary renal cell cancer.
Multimodality imaging is required for accurate diagnosis, staging and treatment of intracardiac metastasis of renal cell cancer.
Owing to high risk of recurrence, lifelong surveillance is mandatory.
Footnotes
Competing interests None.
Patient consent Obtained.